Edition:
United States

People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

4.15USD
20 Oct 2017
Change (% chg)

$-0.01 (-0.24%)
Prev Close
$4.16
Open
$4.20
Day's High
$4.25
Day's Low
$4.02
Volume
1,960,745
Avg. Vol
1,756,611
52-wk High
$7.10
52-wk Low
$3.15

Fenton, Mary 

Ms. Mary Kay Fenton is Chief Financial Officer, Executive Vice President of the Company. Prior to joining Achillion in October 2000, Ms. Fenton, a certified public accountant, held various positions within the Technology Industry Group at PricewaterhouseCoopers LLP, an independent registered public accounting firm, from 1991 to 2000, most recently as Senior Manager responsible for the life sciences practice in Connecticut. Prior to 1991, Ms. Fenton was an economic development associate in the nonprofit sector. Ms. Fenton is on the Executive Committee of the board of directors of Connecticut Business and Industry Association, a representative business organization. Ms. Fenton holds an M.B.A. in Finance from the Graduate School of Business at the University of Connecticut and an A.B. in Economics from the College of the Holy Cross.

Basic Compensation

Total Annual Compensation, USD 506,158
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,217,560
Fiscal Year Total, USD 1,723,720

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

4,947,740

Mary Fenton

1,723,720

Martha Manning

--

David Apelian

2,493,280

Joseph Truitt

1,740,040
As Of  30 Dec 2014